Pfizer Limited (BOM:500680)
India · Delayed Price · Currency is INR 4,741.30
+12.75 (0.27%)
At close: Jul 13, 2026
Pfizer Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Pfizer stock has a consensus rating of "Strong Buy" and an average price target of ₹6,246. The average 1-year stock price forecast is 31.74% higher than the current stock price, while the lowest is ₹5,734 (+20.94%) and the highest is ₹7,500 (+58.18%).
Price Target: ₹6,246 (+31.74%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Pfizer stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 4 |
Financial Forecast
Revenue This Year
27.24B
from 25.20B
Increased by 8.11%
Revenue Next Year
29.82B
from 27.24B
Increased by 9.46%
EPS This Year
181.77
from 165.88
Increased by 9.58%
EPS Next Year
203.07
from 181.77
Increased by 11.72%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 |
|---|---|---|
| High | 27.7B | |
| Avg | 27.2B | |
| Low | 26.4B |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 10.0% | |
| Avg | 8.1% | |
| Low | 5.0% |
EPS Forecast
| EPS | 2027 | 2028 |
|---|---|---|
| High | 192.20 | |
| Avg | 181.77 | |
| Low | 173.50 |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | 15.9% | |
| Avg | 9.6% | |
| Low | 4.6% |